The Effectiveness of Erlotinib Against Brain Metastases in Non-Small Cell Lung Cancer Patients

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation

(2010) R. Porta et al.   EUROPEAN RESPIRATORY JOURNAL

Epidermal Growth Factor Receptor Exon 19 Deletions Predict Complete Regression of Multiple Intracranial Metastases in Two Cases of Non-small Cell Lung Cancer Treated with Erlotinib

(2010) Giovanni Benedetti et al.   Journal of Thoracic Oncology

A Case of Radiation Recall Pneumonitis Induced by Erlotinib, Which Can be Related to High Plasma Concentration

(2010) Yosuke Togashi et al.   Journal of Thoracic Oncology

EGFR-TKI and lung adenocarcinoma with CNS relapse: interest of molecular follow-up

(2009) A-M. Ruppert et al.   EUROPEAN RESPIRATORY JOURNAL

Efficacy of Erlotinib for Brain and Leptomeningeal Metastases in Patients with Lung Adenocarcinoma Who Showed Initial Good Response to Gefitinib

(2009) Tatsuya Katayama et al.   Journal of Thoracic Oncology

Erlotinib therapy in a patient with non-small-cell lung cancer and brain metastases

(2008) Giuseppe Altavilla et al.   JOURNAL OF NEURO-ONCOLOGY

An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC): Data report from Italy

(2008) Marcello Tiseo et al.   LUNG CANCER

Erlotinib in Patients with Previously Irradiated, Recurrent Brain Metastases from Non-Small Cell Lung Cancer: Two Case Reports

(2008) Joachim von Pawel et al.   ONKOLOGIE